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ABSTRACT
Titania nanotubes (TiO2-NTs) are a potential drug vehicle for use in nanomedicine. To this end, a preliminary 
study of the interaction of a model cell with TiO2-NTs has been carried out. TiO2-NTs were first conjugated 
with a fl uorescent label, fl uorescein isothiocyanate (FITC). FITC-conjugated titania nanotubes (FITC-TiO2-NTs) 
internalized in mouse neural stem cells (NSCs, line C17.2) can be directly imaged by confocal microscopy. The 
confocal imaging showed that FITC-TiO2-NTs readily entered into the cells. After co-incubation with cells for 
24 h, FITC-TiO2-NTs localized around the cell nucleus without crossing the karyotheca. More interestingly, the 
nanotubes passed through the karyotheca entering the cell nucleus after co-incubation for 48 h. Atomic force 
microscopy (AFM) and transmission electron microscopy (TEM) were also employed in tracking the nanotubes 
in the cell. These results will be of benefi t in future studies of TiO2-NTs for use as a drug vehicle, particularly for 
DNA-targeting drugs.
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Introduction
It is predicted that nanotechnology has the potential 
to revolutionize cancer diagnosis and therapy [1 3]. 
Nanoparticles (NPs) possessing special characteristics 
can carry multiple therapeutic drugs and imaging 
agents to a tumor site [4 8]. Several therapeutic 
nanocarriers have already been approved for clinical 
trials and use. A particularly desirable target of the 
drug nanovehicle is the cellular nucleus, in which 
the most important genetic information DNA is 
concentrated, enabling some DNA-targeting drugs to 
kill tumor cells via DNA impairment. 
In 2004, Pantarotto et al. functionalized carbon 
nanotubes with fluorescein isothiocyanate (FITC) 
and demonstrated by using confocal microscopy 
that functionalized carbon nanotubes (CNTs) were 
able to cross the cell membrane and accumulate 
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in the cytoplasm or reach the nucleus [9]. In 2007, 
Porter et al. showed by using transmission electron 
microscopy (TEM) that single walled CNTs entered 
the cytoplasm and localized within the cell nucleus 
[10]. Oyelere et al. demonstrated that gold nanorods 
conjugated directly to an SV40 virus nuclear 
localization signal (NLS) peptide could efficiently 
enter cells, and then translocate to both the cytoplasm 
and the nucleus portion [11]. 
To date, utilizing NPs to target the nucleus has not 
proved very successful due to the poor permeability 
of the nuclear membranes. Thus, design and synthesis 
of appropriate drug carriers capable of entering the 
cell nucleus are imperative. Nano titania (TiO2) is 
biocompatibile and has diverse uses in molecular 
biology [12 15]. Guzman et al. [16] used TiO2 NPs to 
label human central nervous system (CNS) stem cells 
in transplantation for noninvasive monitoring. Their 
results indicated that cells labeled with NPs survived 
longer in a site-specifi c manner, differentiating them 
from the unlabeled cells, suggesting that TiO2-NTs 
are a promising drug delivery vector after the surface 
has been specifi cally functionalized. 
Herein, we present a labeling approach using 
TiO2-NTs conjugated with FITC. FITC-conjugated 
titania nanotubes (FITC-TiO2-NTs) can be observed by 
using confocal microscopy, with one direct-viewing 
observation for the internalization and translocation 
of titania nanotubes. Notably, by means of confocal 
microscopy together with TEM and atomic force 
microscopy (AFM), we have found that TiO2-NTs can 
cross the karyotheca and enter the nucleus of mouse 
neural stem cells. 
1. Experimental 
1.1   Materials
All chemicals were commercially available. Ethanol 
and NH4OH were supplied by Sinopharm Chemical 
Reagent Co. Ltd., China. Tetraethoxysilane (TEOS), 
(3-aminopropyl)triethoxysilane (APTS), and FITC 
were purchased from Sigma Aldrich. The fl uorescent 
dye FM4-64 (N-(3-triethylammoniumpropyl)-4-(p-
diethylaminophenylhexatrienyl)-pyridinium 2Br) 
was obtained from Invitrogen Corp. 4,6-Diamidino-
2-phenylindole (DAPI) and KeyGen nuclei isolation 
kit were purchased from Nanjing KeyGen Biotech 
Co. Ltd., China. Standard solutions of titanium were 
purchased from Shanghai Institute of Measurement 
and Testing Technology. Dulbecco’s Modified 
Eagle’s Medium (DMEM), fetal bovine serum, and 
horse serum were purchased from Hyclone. Mouse 
neural stem cells (NSCs, line C17.2) were provided 
by Dr. E. Snyder of Harvard Medical School, USA. 
1.2   FITC modifi ed nanotubes 
The TiO2-NT sample was given as a courtesy by 
Suzhou Institute of Nano-tech and Nano-bionics, 
Chinese Academy of Sciences (CAS). The synthesis 
process was according to Kasuga et al. [17 19]. Briefl y, 
TiO2 powders were prepared by the sol–gel method. 
The ultrasonic pretreated TiO2 powder (200 mg) was 
dispersed in 140 mL of 10 mol/L NaOH solution. The 
solution was heated to 130 °C for 35 h in an oven and 
then cooled naturally in air. Next, the solution was 
centrifuged at a 8000 rpm and the precipitate was 
collected. Finally, after carrying out a hydrothermal 
reaction, the precipitate was fi ltered and washed with 
0.1 mol/L HCl solution and distilled water, and dried 
at 60 °C overnight.
FITC-APTS (fluorescein linked (3-aminopropyl)-
triethoxysilane) conjugate was synthesized following 
the method of Santra et al. [20]. A liquid mixture 
was prepared by adding 1 mL of NH4OH to 30 mL 
of absolute ethanol, and stirred for 5 min. Then, 1.4 
mL of NH4OH, 3 mg of TiO2-NTs, and 50 μL of TEOS 
were added, and the mixture stirred for 10 min. 
After addition of 100 μL of FITC-APTS conjugate, 
the solution was stirred for 24 h to complete the 
preparation, followed by washing, centrifugation, 
and dilution of the supernatant with phosphate 
buffered saline (PBS) to 100 μg/mL. Finally, the 
resulting FITC-TiO2-NTs sample was sterilized and 
stored in the dark.
1.3   Cell culture 
Mouse NSCs were cultured in high-glucose DMEM 
with 10% fetal bovine serum (Sigma), 5% horse 
serum (Gibco), glutamine (1 mmol/L), penicillin 
(100 U/mL), and streptomycin (100 μg/mL ). Culture 
dishes were placed under humidified 5% CO2 and 
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95% air at 37 °C. Cultured stem cells were incubated 
with the FITC-TiO2-NTs for a predetermined period.
1.4    AFM study 
Cell  imaging was performed using an AFM 
(Shimadzu SPM 9600) in the contact mode. For 
sample preparation, the stem cells were seeded 
at a density of 5×104 cells/mL per glass coverslip 
and grown for 12 h. Then the cells were exposed to 
25 μL of TiO2-NTs (100 μg/mL) for 12 h under the 
culture conditions. The cells were then fixed with 
freshly prepared and chilled 4% paraformaldehyde 
for 30 min. After fixation, the cells were washed 
five times with chilled PBS (pH 7.0) and coverslips 
were attached to metallic packs with double-sided 
conducting tape, followed by several washes with 
chilled PBS (pH 7.0). Coverslips were blow-dried for 
15 min before investigation. All phase images were 
recorded in the contact mode at a scanning frequency 
of 1.5 Hz.
1.5    Confocal laser scanning microscopy study
NSCs were seeded at a density of 5×104 cells/mL 
for 24 h or 48 h in a Petri dish specifically for the 
confocal study. The cells were measured with 
a spinning disk confocal microscope (FV-1000, 
Olympus) after incubation in culture medium with 
25 μL (100 μg/mL) of FITC-TiO2-NTs at 37 °C for 
24 h or 48 h. To confirm whether the nucleus was 
indeed the localization site for the nanotubes, the 
cell nuclei were stained in blue with 4,6-diamidino-
2-phenylindole after 48 h incubation, and then the 
system was subject to confocal measurement. 
The endocytosis pathways were investigated as 
follows. NSCs were plated onto 60 mm cell culture 
coverslips and cultured at 37 °C overnight. Then cells 
were incubated with 75 μL of 100 μg/mL FITC-TiO2-
NTs and 175 μL of 100 μg/mL FM4-64 in a serum-free 
medium at 37 °C for 2 h. The laser wavelengths used 
were: λex = 488 nm and λem = 530 nm for FITC; λex 
= 558 nm and λem = 734 nm for FM4-64. 
1.6    TEM study 
NSCs were seeded at a density of 1×106 cells in a 60 
mm tissue culture dish and grown overnight. The 
cells were treated with 75 μL of 100 μg/mL FITC-
TiO2-NTs for another 48 h. After that, they were 
thoroughly washed with chilled PBS, pelleted by 
centrifugation, and fixed with 0.1% glutaraldehyde. 
Cell images were recorded at 60 kV using TEM 
(Philips CM 120 Holland).
1.7    Nuclear isolation
Nuclear isolation was performed using the KeyGen 
nuclei isolation kit according to the supplied protocol. 
The kit supplies a complete set of lysis reagents that 
enable the separation of nuclear extract from cultured 
cells. Briefly, the adherent cells were treated with 
pancreatic enzyme and then centrifuged at 800 rpm 
for 5 min. After estimating the packed cell volume, 
the appropriate amount (10 times the cell volume) 
of pre-chilled lysis buffer was added. The cell pellets 
were resuspended and reagent A (1/20th of the the 
cell volume) was added and the mixture subjected 
to vigorous vortex mixing. Cells were incubated in 
ice for 10 20 min, then shocked every 30 s with a 
vortex for 3 5 min. Isolated nuclei were above 95% 
as observed using phase contrast microscopy. After 
centrifuging at 1000 rpm for 3 min, the cell pellets 
were resuspended with lysis buffer (10 times the 
cell volume). The mixture was then centrifuged at 
1000 rpm for 3 min, and then resuspended with 0.5 
mL medium buffer A. Ice-cold medium buffer B 
was added to another clean pre-chilled tube. Cell 
suspensions were slowly poured into the medium 
buffer B. Finally, the mixture was centrifuged at 
1000 rpm for 10 min, the supernatant was discarded 
and the fi onal product stored at 80 °C until use. All 
centrifugation procedures were performed at 4 °C.
1.8    Inductively coupled plasma (ICP) study
Mouse NSCs were seeded at a density of 1×106 cells 
in a 60 mm tissue culture dish and grown overnight. 
The cells were treated with 75 μL of 100 μg/mL 
FITC-TiO2-NTs for another 48 h. To determine the 
endocytosis mechanism of FITC-TiO2-NTs, NSCs 
were seeded at a density of 1×106 cells in a 60 mm 
tissue culture dish and grown overnight. The cells 
were treated with 75 μL of 100 μg/mL FITC-TiO2-
NTs for another 4 h at 37 °C and on a parallel with 
4 °C. After that, they were washed with chilled PBS 
six times to ensure that the FITC-TiO2-NTs on the 
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cell surface were well cleaned. The cells were treated 
with pancreatic enzyme and then centrifuged at 
1200 rpm for 5 min. The supernatant was aspirated, 
and the cell pellet was nitrified with aqua regia. 
After evaporation of the samples at 90 °C for 6 h, the 
mixture was diluted with 2% HNO3 to 10 mL. 2% 
(v/v) HNO3 solution was used as the blank sample 
to determine the detection limit (DL). Ten parallel 
determinations of a sample were done with a mean 
of 0.0182 μg/mL and a standard deviation (SD) of 
0.000 241μg/mL. ICP analysis was carried out using 
a Prodigy ICP (Leeman Labs., USA). 
2. Results and discussion   
2.1    Characterization of TiO2-NTs  
2.1.1  TEM and confocal imaging
The TEM image (Fig. 1(a)) shows the shape and size of 
originally unmodified TiO2-NTs. The confocal image 
(Fig. 1(b)) shows that the FITC-TiO2-NTs have good 
fluorescence intensity. The TEM image in Fig. 1(c) 
shows the size and morphology of FITC-TiO2-NTs.
 
2.1.2  X-ray diffraction (XRD)
Figure 2 shows the XRD patterns of unmodified 
TiO2-NTs (Fig. 2(a)) and FITC-TiO2-NTs (Fig. 2(b)). 
The characteristic reflection peaks of the rutile TiO2 
structure can be observed. Comparison with the 
standard pattern for TiO2 [21, 22] shows that the 
the peaks can be assigned to the 110, 101, 111, 211, 
220, and 301 reflections. The XRD patterns of the 
unmodifi ed TiO2-NTs and FITC-TiO2-NTs are similar, 
showing that TiO2 exists as a single rutile phase in 
both materials.
   
2.2   Morphological changes of cell surface after 
incubation
When combined with conventional tools, AFM can 
provide an understanding of the cellular secretion 
Figure 1 (a) TiO2-NTs with average diameter <10 nm and length <400 nm; (b) confocal image of FITC-TiO2-NTs; (c) TEM image 
of FITC-TiO2-NTs 
(a) (b) (c)
Figure 2 XRD patterns: (a) TiO2-NTs; (b) FITC-TiO2-NTs 
(a) (b)
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and membrane fusion at the molecular level [23 25]. 
Figs. 3(a) and 3(d) reveal that many pit-like structures 
(depressions) appear in the surface of the cellular 
membrane whilst Figs. 3(b) and 3(e) show the 3-D 
height plots. The depression openings range from 200 
to 250 nm in diameter and the cone-shaped pits range 
from 25 to 35 nm in relative depth. The analysis data 
(Fig. 3(c)) of one depression opening (Fig. 3(a)) show 
its diameter to be 234 nm and depth 30 nm. These 
pits imply that the footprints remained when NPs 
were internalized into the cell.
2.3    Confocal imaging of intracellular uptake and 
localization of NTs 
In Fig. 4, the confocal images show that FITC-
TiO2-NTs can be internalized into the cells after 
incubation for 24 h. FITC-TiO2-NTs localize around 
the cell nucleus without crossing the karyotheca. To 
confi rm whether the nucleus was indeed 
the localization site for TiO2-NTs, the 
incubation time was prolonged to 48 h 
and the cell nucleus was stained in blue 
with DAPI. The exciting results, as shown 
in Fig. 5, demonstrate that FITC-TiO2-NTs 
eventually pass across the karyotheca to 
localize in the nucleus.
 Singh et al. reported that TiO2 NPs 
were rapidly taken up by cells, generally 
as membrane-bound aggregates and 
large intracellular aggregates in vesicles, 
vacuoles, and lamellar bodies, but no 
particles were observed inside nuclei or 
any other vital organelles [26]. Only a few 
examples have been reported of carbon 
Figure 4 Confocal images of NSCs obtained after 
incubation for 24 h with FITC-TiO2-NTs: (a) FITC-TiO2-
NTs (green color) in NSCs; (b) nuclei stained blue with 
DAPI dye; (c) merger of (a) and (b); (d) merger of (c) and 
bright field image of NSCs. The merged images show 
that FITC-TiO2-NTs accumulate mainly in the cytoplasm  
Figure 3 AFM images of the morphological change in cell surface after incubation 
of cells and FITC-TiO2-NTs for 12 h: (a) and (d) are the top views of AFM images; 
(c) is the analysis data for (a); (f) is a control image; (b), (e) and (g) are the height 









548 Nano Res (2009) 2: 543 552
Nano Research
Figure 5 Confocal images of NSCs incubated with FITC-TiO2-NTs for 48 h; (a) FITC-TiO2-NTs (green 
color) in NSCs; (b) cell nuclei stained blue with DTPI dye; (c) merger of (a) and (b); (d), (e) and (f) 
are the merged images of (a), (b) and (c), respectively, with the bright fi eld image of NSCs. The 
merged images show that FITC-TiO2-NTs accumulate mainly in the nuclei and that NSCs grew well 
after co-incubation with FITC-TiO2-NTs for 48 h
Figure 6 TEM image of NSCs after co-incubation with FITC-TiO2-NTs for 48 h. (a) image of a 
control cell; (b) NTs in cell nucleus. N denotes the nuclear membrane and NT the FITC-TiO2-NTs
nanotubes passing through the cell membrane and 
becoming located in the nucleus [27, 28]. The present 
results have shown that the functionalized TiO2-NTs 
can pass through the cell membrane and then locate 
inside the nuclei after long term incubation (Fig. 5). 
Importantly, TEM confi rms further that the modifi ed 
NTs are indeed present in the nucleus (Fig. 6). 
 
2.4   Mechanistic studies 
The cellular internalization of nanoparticles seems 
very complex and involves multiple endocytic 
m e c h a n i s m s  i n c l u d i n g  c l a t h r i n - m e d i a t e d 
endocytosis, caveolae-mediated endocytosis, as well 
as clathrin- and caveolae-independent endocytosis, 
rather than one single endocytic pathway. The size, 
coating, and molecular properties of nanoparticles 
and their intracellular destination, as well as the cell 
type, may determine the preferred endocytic pathway 
for their uptake [27]. Futhermore, cells may take up 
exogenous macromolecules by their internalization 
pathways, such as endocytosis, macropinocytosis or 
phagocytosis [29].
(a) (b)
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To determine how many TiO2-NTs were taken 
up by the mouse NSCs and to confirm that FITC-
TiO2-NTs were located in the nucleus, elemental 
analysis by ICP was carried out. Table 1 shows that 
the cellular uptake of FITC-TiO2-NTs by NSCs at 
37 °C increased continuously with increasing time. 
However, at 4 °C, the cellular content (0.019 μg/mL) 
was near the value for the blank sample and less than 
the detection limit. Therefore, the cellular uptake is 
inhibited at 4 °C, and we conclude that it involves an 
energy-dependent endocytosis mechanism.
In order to further investigate the cellular uptake 
process of FITC-TiO2-NTs, NSCs were co-treated 
with FITC-TiO2-NTs and FM4-64. Dye FM4-64 is 
a lipophilic styryl compound used in a variety 
of studies involving the plasma membrane and 
vesiculation [30, 31] and is also used as a common 
membrane-selective marker for the endocytosis 
process. As shown in Fig. 7(c), the merged panel 
image clearly shows the endosome vesic les 
enwrapping FITC-TiO2-NTs. The co-localization of 
FITC-TiO2-NTs (green) and FM4-64 (red) directly 
reveals that the FITC-TiO2-NTs are transported into 
cells via the endocytosis process, which is consistent 
with the AFM, TEM, and ICP results. This confirms 
that the cellular uptake process of FITC-TiO2-NTs 
involves energy-dependent endocytosis.
In addition, NSC nuclei were isolated and 
purified after co-incubation with FITC-TiO2-NTs at 
37 °C for 48 h, and the content of FITC-TiO2-NTs 
inside the nuclei was measured by ICP. As shown 
in Table 1, the concentration of titanium inside the 
nuclei is 0.113 μg/mL, which is consistent with the 
confocal and TEM results shown in Figs. 5 and 6. 
Although the nuclear targeting mechanism of FITC-
TiO2-NTs is not well known, there has been some 
published work showing that another typical one-
dimensional nanomaterial, CNTs, can cross the 
nuclear membrane and be retained in the nucleus [9, 
32]. Cheng et al. inferred that the CNT-accumulation 




Location In NSCs In nuclei In NSCs
Co-incubation time (h) 4 24 48 48 4
Conc. of Ti (μg/mL) 0.096 ± 0.008 0.174 ± 0.009 0.212 ± 0.004 0.113 ± 0.012 0.019 ± 0.0002
Figure 7 Confocal microscopy images of NSCs co-incubated for 2 h at 37 °C with a solution containing FITC-TiO2-NTs 
((a), green fl uorescence) and the endocytosis marker FM4-64 ((b), red fl uorescence). The merged image of (a) and (b) ((c), 
yellow fl uorescence) shows that the FITC-TiO2-NTs are co-localized with FM4-64 in the endosome vesicles, and thus the 
internalization of FITC-TiO2-NTs via the endocytosis process is confi rmed
(a) (b) (c)
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in nuclei might come from CNTs binding with 
specific nuclear proteins or nucleic acids [33]. In 
general, a nuclear pore complex (NPC), with a size 
range between 30 nm and 60 nm, is the only known 
route for direct nucleocytoplasmic exchange of 
matter [28]. TiO2-NTs have average diameter less 
than 10 nm, which facilitates penetration of TiO2-
NTs into the cell nucleus through NPC. Escape from 
endosomal/lysosomal vesicles and accumulation 
in the perinuclear region is another pathway for 
nanoparticle transport from the cytoplasm into 
the cell nucleus, since this may facilitate physical 
contact of nanoparticles with NPCs. In fact, the 
confocal images have shown that FITC-TiO2-NTs 
predominantly accumulate in the perinuclear region 
of NSCs. Therefore, we infer that FITC-TiO2-NTs are 
internalized into nuclei through NPCs, and that some 
specific nuclear proteins in the cell cytoplasm may 
play an important role during the passage of FITC-
TiO2-NTs through the NPC.
 The most important genetic information—
DNA—concentrates in the nucleus, thus enabling 
some DNA-targeting drugs to kill tumor cells via 
DNA impairment. Oyelere et al. reported in 2007 
that peptide-conjugated gold nanorods translocated 
into both the cytoplasm and the nucleus portion [11]. 
This study demonstrated the possibility that gold 
nanorods can be used for nuclear targeting. But, 
on the other hand, there have been some reports of 
the potential toxicity of gold nanoparticles, such as 
their cytotoxicity [34 37], limited biocompatibility 
or  oxidat ive stress  [38 40] .  Given the good 
biocompatibility of TiO2-NT, our results suggest 
that TiO2-NT is a good candidate as a nanovehicle 
for cancer drug delivery. Generally, nanotubes 
have significant advantages over nanoparticles as a 
medicine carrier. In contrast to the spherical NPs, the 
geometry of NTs might allow them to be multiply 
functionalized by different molecules that allow the 
nanovehicle to carry the drug more effi ciently to the 
target [41, 42]. For the purpose of cancer therapy, 
the exploration of nuclear DNA-targeting NTs 
carrying antitumor drugs is of particular importance. 
Undoubtedly, it is one of the difficult challenges in 
the emerging arena of cancer nanotechnology [43, 
44].
3. Conclusions
We present a simple method for imaging intracellular 
TiO2-NTs using confocal microscopy and TEM. It is 
demonstrated for the fi rst time that TiO2-NTs are able 
to cross the karyotheca and enter the nucleus. Hence, 
we infer that TiO2 nanotubes are promising future 
nanovehicles for DNA-targeting drugs in cancer 
therapy. We are only at the earliest stages in cancer 
nanotechnology and the translocation mechanism of 
the FITC-TiO2-NTs across the karyotheca remains to 
be elucidated. 
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